1.A Case of Dapsone Syndrome.
Jeong Kyu SEOH ; Hye Kyong BAE ; Jae Seung YANG ; Eung Deok CHOI ; Baek Keun LIM ; Jong Soo KIM
Journal of the Korean Pediatric Society 1988;31(10):1376-1380
No abstract available.
Dapsone*
2.Wells Syndrome: Response to Dapsone Therapy.
Charalambos BOKOTAS ; Anargyros KOURIS ; Christina STEFANAKI ; Themis SGOTZOU ; Elefteria CHRISTOFIDOU ; George KONTOCHRISTOPOULOS
Annals of Dermatology 2014;26(4):541-542
No abstract available.
Dapsone*
3.Drug Hypersensitivity Syndrome Associated Dapsone.
Korean Journal of Dermatology 2012;50(5):475-476
No abstract available.
Dapsone
;
Drug Hypersensitivity
4.Dapsone therapy for immune thrombocytopenic purpura: old but still unfamiliar.
Blood Research 2017;52(2):77-78
No abstract available.
Dapsone*
;
Purpura, Thrombocytopenic, Idiopathic*
5.Role of ascorbic acid in dapsone induced methemoglobinemia
Kamal Kant SAHU ; Ajay Kumar MISHRA
Clinical and Experimental Emergency Medicine 2019;6(1):91-92
No abstract available.
Ascorbic Acid
;
Dapsone
;
Methemoglobinemia
6.A Case of Palisaded Neutrophilic and Granulomatous Dermatitis Treated with Dapsone.
Yeon Woong KIM ; Moonhyung YOU ; Joongoon KIM ; Dong Hoon SHIN ; Jong Soo CHOI
Korean Journal of Dermatology 2018;56(8):513-514
No abstract available.
Dapsone*
;
Dermatitis*
;
Neutrophils*
7.Two Cases of Lupus Miliaris Disseminatus Faciei Treated with Dapsone.
Korean Journal of Dermatology 1996;34(6):1016-1020
Lupus miliaris disseminatus faciei (LMDF) is an asymptomatic papular eruption affecting the central area of the face. It runs a chronic course and can involute spontaneously with scarring. The treatment of LMDF has not been satisfactory despite the use of many different kinds of topical and systemic agents. In the early 1980s, Kumano et al. reported their experiences with this disease using dapsone; the efficacy of dapsone was described as excellent. With this report in mind, we have used dapsone(50-100mg/d) in 2 patients with LMDF, and a marked irnprovement or almost cure of the skin disease were recognized.
Cicatrix
;
Dapsone*
;
Humans
;
Skin Diseases
8.A Case of Jessner's Lymphocytic Infiltration.
Bong Seok SHIN ; Hyun Deok SEO ; Chan Ho NA ; Kyu Churl CHOI ; Byoung Soo CHUNG
Korean Journal of Dermatology 2008;46(7):977-980
Jessner's lymphocytic infiltration of the skin (JLIS) is a well-known but poorly understood disorder. Some doubt still exists about whether it is a distinct disease or a variant of lupus erythematosus or, less commonly, polymorphous light eruption, cutaneous lymphoid hyperplasia. An effective therapy is still unavailable for JLIS. We report a patient with JLIS which was successfully treated with dapsone and intermittent systemic glucocorticoid therapy.
Dapsone
;
Humans
;
Hyperplasia
;
Light
;
Skin
9.Dapsone Hypersensitivity Syndrome with EBV Reactivation.
Jae We CHO ; Kyu Suk LEE ; Gil HAN
Korean Journal of Dermatology 2014;52(5):358-360
No abstract available.
Dapsone*
;
Herpesvirus 4, Human*
;
Hypersensitivity*
10.A Case of Steroid-resistant Neutrophilic Dermatosis of the Hands Treated with Dapsone.
Eui Hyun OH ; Dong Uk CHEON ; Joo Yeon KO ; Young Suck RO ; Jeong Eun KIM
Korean Journal of Dermatology 2017;55(6):374-376
No abstract available.
Dapsone*
;
Hand*
;
Neutrophils*
;
Skin Diseases*
Result Analysis
Print
Save
E-mail